Abstract
The SARS-CoV-2 Delta variant has evolved as the dominant strain of the current pandemic. Studies have shown that this variant has increased infectivity/viral load, and reduced neutralization by the host antibodies from convalescent patients/vaccinees. Clinically, Delta variant infection has been observed/documented in convalescent patients/vaccinees, although with less incidence of severe diseases, but can serve as reservoir to spread the infection to the unvaccinated. The current understanding (as of 18 August 2021) on the virologic aspect (including the amino acid substitutions), clinical implications, and public health implications will be discussed in this mini review, and recommendations to health authorities will be provided.
| Original language | English |
|---|---|
| Pages (from-to) | 287-292 |
| Number of pages | 6 |
| Journal | Precision Clinical Medicine |
| Volume | 4 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Dec 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
User-Defined Keywords
- coronavirus
- COVID-19
- Delta variant
- SARS-CoV-2
- transmissibility
- vaccine
Fingerprint
Dive into the research topics of 'COVID-19 Delta variants—Current status and implications as of August 2021'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver